Company profile: Synergy Pharmaceuticals
1.1 - Company Overview
Company description
- Provider of biopharmaceutical research and development focused on novel therapies for the treatment of gastrointestinal conditions.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Synergy Pharmaceuticals
Innovate Biopharma
HQ: United States
Website
- Description: Provider of clinical-stage biotechnology drug candidates for gastroenterological and orphan disorders: INN-202 (Phase 3, celiac disease), INN-329 (Phase 3, enhances pancreatic duct visualization in MRCP diagnostics), INN-108 (Phase 2, mild to moderate ulcerative colitis and other inflammatory bowel disorders), INN-217 (Phase 1/2, nonalcoholic steatohepatitis), and INN-289 (Phase 1, subset of Crohn’s disease).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Innovate Biopharma company profile →
ARYx Therapeutics
HQ: United States
Website
- Description: Provider of pharmaceutical solutions focused on retrometabolic drug design to improve the safety of oral therapies for chronic diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ARYx Therapeutics company profile →
Rodeo Therapeutics
HQ: United States
Website
- Description: Provider of small-molecule therapies targeting novel enzyme targets and biological pathways to promote tissue repair and regeneration, with an initial focus on treating inflammatory bowel disease and promoting blood cell reconstitution following bone marrow.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rodeo Therapeutics company profile →
Ostoform
HQ: Ireland
Website
- Description: Provider of ostomy skin health devices as a spin-out medical device company from the University of Limerick, Ireland, offering the Ostoform Seal with FLOWASSIST to direct high liquid stoma output away from skin into the pouch to help reduce skin complications and leakage, and the FLOWASSIST 2-Piece Pouch with baseplate-integrated technology for easier management of problematic stomas, durability, and security.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ostoform company profile →
Furiex Pharmaceuticals
HQ: United States
Website
- Description: Provider of drug development collaboration and compound partnering services, working with pharmaceutical and biotechnology companies to enhance the value of their drug candidates through a novel development approach, focused on improving partnered drug programs primarily in the United States.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Furiex Pharmaceuticals company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Synergy Pharmaceuticals
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Synergy Pharmaceuticals
2.2 - Growth funds investing in similar companies to Synergy Pharmaceuticals
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Synergy Pharmaceuticals
4.2 - Public trading comparable groups for Synergy Pharmaceuticals
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →